It is vegan-friendly, non-GMO, gluten-free, lactose-free, and sugar-free, completely free from hormones, antibiotics, and stimulants
The FDA-approved dosing for both products includes a gradual dose escalation schedule to minimize gastrointestinal symptoms
Clinicians also should be vigilant about monitoring patients for potential anemia, especially those already at higher risk, such as women and people with T2D, overweight or obesity, preexisting anemia, or CKD
Confocal microscopy demonstrated both exendin-4-FITC and lixisenatide-FITC to be localised within GLP-1R-containing endosomes 30 minutes post-stimulation (Figure 3G)
GLP-1s are weekly subcutaneous injections